The medical world is seeing a surge in attention towards a rare yet impactful condition—Osteogenesis Imperfecta (OI), often referred to as brittle bone disease. Characterized by fragile bones that break easily, this genetic disorder is finally getting the research and innovation push it deserves. What’s exciting? The Osteogenesis Imperfecta Treatment Market is heating...